Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy

11 May 2026 (13:15 - 13:29)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award (YIA) Basic Science Gene Therapy, Cell Therapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by